Literature DB >> 24484751

Computer-assisted diagnosis in renal nuclear medicine: rationale, methodology, and interpretative criteria for diuretic renography.

Andrew T Taylor1, Ernest V Garcia2.   

Abstract

The goal of artificial intelligence, expert systems, decision support systems, and computer-assisted diagnosis (CAD) in imaging is the development and implementation of software to assist in the detection and evaluation of abnormalities, to alert physicians to cognitive biases, to reduce intraobserver and interobserver variability, and to facilitate the interpretation of studies at a faster rate and with a higher level of accuracy. These developments are needed to meet the challenges resulting from a rapid increase in the volume of diagnostic imaging studies coupled with a concurrent increase in the number and complexity of images in each patient data. The convergence of an expanding knowledge base and escalating time constraints increases the likelihood of physician errors. Errors are even more likely when physicians interpret low-volume studies such as technetium-99m-mercaptoacetyltriglycine diuretic scans where imagers may have had limited training or experience. Decision support systems include neural networks, case-based reasoning, expert systems, and statistical systems. iRENEX (renal expert) is an expert system for diuretic renography that uses a set of rules obtained from human experts to analyze a knowledge base of both clinical parameters and quantitative parameters derived from the renogram. Initial studies have shown that the interpretations provided by iRENEX are comparable to the interpretations of a panel of experts. iRENEX provides immediate patient-specific feedback at the time of scan interpretation, can be queried to provide the reasons for its conclusions, and can be used as an educational tool to teach trainees to better interpret renal scans. It also has the capacity to populate a structured reporting module and generate a clear and concise impression based on the elements contained in the report; adherence to the procedural and data entry components of the structured reporting module ensures and documents procedural competency. Finally, although the focus is CAD applied to diuretic renography, this review offers a window into the rationale, methodology, and broader applications of computer-assisted diagnosis in medical imaging.
© 2013 Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24484751      PMCID: PMC3995408          DOI: 10.1053/j.semnuclmed.2013.10.007

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  61 in total

1.  Guidelines for standard and diuretic renography in children.

Authors:  I Gordon; P Colarinha; J Fettich; S Fischer; J Frökier; K Hahn; L Kabasakal; M Mitjavila; P Olivier; A Piepsz; U Porn; R Sixt; J van Velzen
Journal:  Eur J Nucl Med       Date:  2001-03

Review 2.  Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology.

Authors:  A Prigent; P Cosgriff; G F Gates; G Granerus; E J Fine; K Itoh; M Peters; A Piepsz; M Rehling; M Rutland; A Taylor
Journal:  Semin Nucl Med       Date:  1999-04       Impact factor: 4.446

3.  Report of the Radionuclides in Nephrourology Committee on renal clearance.

Authors:  M D Blaufox; M Aurell; B Bubeck; E Fommei; A Piepsz; C Russell; A Taylor; H S Thomsen; D Volterrani
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

4.  Estimation of residual urine and urine flow rates without urethral catheterization.

Authors:  B S Strauss; M D Blaufox
Journal:  J Nucl Med       Date:  1970-02       Impact factor: 10.057

5.  Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transplants.

Authors:  Y Li; C D Russell; J Palmer-Lawrence; E V Dubovsky
Journal:  J Nucl Med       Date:  1994-05       Impact factor: 10.057

6.  Interpretation of captopril transplant renography using a feed forward neural network.

Authors:  D Hamilton; U J Miola; D Mousa
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

7.  NORA: a simple and reliable parameter for estimating renal output with or without frusemide challenge.

Authors:  A Piepsz; M Tondeur; H Ham
Journal:  Nucl Med Commun       Date:  2000-04       Impact factor: 1.690

8.  Feasibility analysis of a case-based reasoning system for automated detection of coronary heart disease from myocardial scintigrams.

Authors:  M Haddad; K P Adlassnig; G Porenta
Journal:  Artif Intell Med       Date:  1997-01       Impact factor: 5.326

9.  When could the administration of furosemide be avoided?

Authors:  Jacob Kuyvenhoven; Amy Piepsz; Hamphrey Ham
Journal:  Clin Nucl Med       Date:  2003-09       Impact factor: 7.794

10.  Automated interpretation of planar thallium-201-dipyridamole stress-redistribution scintigrams using artificial neural networks.

Authors:  G Porenta; G Dorffner; S Kundrat; P Petta; J Duit-Schedlmayer; H Sochor
Journal:  J Nucl Med       Date:  1994-12       Impact factor: 10.057

View more
  4 in total

1.  Overall indices for assessing agreement among multiple raters.

Authors:  Jeong Hoon Jang; Amita K Manatunga; Andrew T Taylor; Qi Long
Journal:  Stat Med       Date:  2018-07-30       Impact factor: 2.373

Review 2.  Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications.

Authors:  Andrew T Taylor
Journal:  J Nucl Med       Date:  2014-03-03       Impact factor: 10.057

3.  Principal component analysis of hybrid functional and vector data.

Authors:  Jeong Hoon Jang
Journal:  Stat Med       Date:  2021-06-23       Impact factor: 2.373

4.  Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on 68Ga-Pentixafor PET/CT Imaging Using Deep Learning Methods.

Authors:  Lina Xu; Giles Tetteh; Jana Lipkova; Yu Zhao; Hongwei Li; Patrick Christ; Marie Piraud; Andreas Buck; Kuangyu Shi; Bjoern H Menze
Journal:  Contrast Media Mol Imaging       Date:  2018-01-08       Impact factor: 3.161

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.